# DPP4inhibitors in Type 1 Diabetes

> **NCT01922817** · PHASE3 · COMPLETED · sponsor: **University of Dundee** · enrollment: 28 (actual)

## Conditions studied

- Type 1 Diabetes
- Hypoglycaemia

## Interventions

- **DRUG:** Saxagliptin

## Key facts

- **NCT ID:** NCT01922817
- **Lead sponsor:** University of Dundee
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2019-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01922817

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01922817, "DPP4inhibitors in Type 1 Diabetes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01922817. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*